Marine molecular machines: heterocyclization in cyanobactin biosynthesis.
Natural products that contain amino-acid-derived (Cys, Ser, Thr) heterocycles are ubiquitous in nature, yet key aspects of their biosynthesis remain undefined. Cyanobactins are heterocyclic ribosomal peptide natural products from cyanobacteria, including symbiotic bacteria living with marine ascidians. In contrast to other ribosomal peptide heterocyclases that have been studied, the cyanobactin heterocyclase is a single protein that does not require an oxidase enzyme. Using this simplifying condition, we provide new evidence to support the hypothesis that these enzymes are molecular machines that use ATP in a product binding or orientation cycle. Further, we show that both protease inhibitors and ATP analogues inhibit heterocyclization and define the order of biochemical steps in the cyanobactin biosynthetic pathway. The cyanobactin pathway enzymes, PatD and TruD, are thiazoline and oxazoline synthetases.
Department of Medicinal Chemistry, College of Pharmacy, University of Utah, Salt Lake City, UT 84112 USA.
John A
JA
McIntosh
Eric W
EW
Schmidt
D000255:Adenosine Triphosphate / Q000378:metabolism; D000595:Amino Acid Sequence; D000818:Animals; D001426:Bacterial Proteins / Q000378:metabolism; D000458:Cyanobacteria / Q000378:metabolism*; D003500:Cyclization; D006571:Heterocyclic Compounds / Q000378:metabolism; D007700:Kinetics; D008969:Molecular Sequence Data; D010456:Peptides, Cyclic / Q000096:biosynthesis*; D013559:Symbiosis; D014561:Urochordata / Q000382:microbiology
D001426:Bacterial Proteins; D006571:Heterocyclic Compounds; D010456:Peptides, Cyclic; D000255:Adenosine Triphosphate